Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.410
+0.140 (11.02%)
May 28, 2025, 4:00 PM - Market closed

Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $152.68 million. The enterprise value is -$35.36 million.

Market Cap 152.68M
Enterprise Value -35.36M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

ACRS has 108.28 million shares outstanding. The number of shares has increased by 27.19% in one year.

Current Share Class 108.28M
Shares Outstanding 108.28M
Shares Change (YoY) +27.19%
Shares Change (QoQ) +28.42%
Owned by Insiders (%) 2.67%
Owned by Institutions (%) 53.06%
Float 67.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.15
Forward PS 29.06
PB Ratio 1.06
P/TBV Ratio 1.06
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.02.

Current Ratio 5.06
Quick Ratio 4.91
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.03% and return on invested capital (ROIC) is -23.19%.

Return on Equity (ROE) -91.03%
Return on Assets (ROA) -18.20%
Return on Invested Capital (ROIC) -23.19%
Return on Capital Employed (ROCE) -30.68%
Revenue Per Employee $277,766
Profits Per Employee -$2.03M
Employee Count 64
Asset Turnover 0.10
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +27.03% in the last 52 weeks. The beta is 0.43, so ACRS's price volatility has been lower than the market average.

Beta (5Y) 0.43
52-Week Price Change +27.03%
50-Day Moving Average 1.34
200-Day Moving Average 1.90
Relative Strength Index (RSI) 58.19
Average Volume (20 Days) 665,674

Short Selling Information

The latest short interest is 4.57 million, so 4.22% of the outstanding shares have been sold short.

Short Interest 4.57M
Short Previous Month 4.45M
Short % of Shares Out 4.22%
Short % of Float 6.81%
Short Ratio (days to cover) 4.99

Income Statement

In the last 12 months, ACRS had revenue of $17.78 million and -$130.21 million in losses. Loss per share was -$1.45.

Revenue 17.78M
Gross Profit -32.68M
Operating Income -54.18M
Pretax Income -59.05M
Net Income -130.21M
EBITDA -53.99M
EBIT -54.18M
Loss Per Share -$1.45
Full Income Statement

Balance Sheet

The company has $105.31 million in cash and $2.48 million in debt, giving a net cash position of $188.04 million or $1.74 per share.

Cash & Cash Equivalents 105.31M
Total Debt 2.48M
Net Cash 188.04M
Net Cash Per Share $1.74
Equity (Book Value) 144.07M
Book Value Per Share 1.33
Working Capital 87.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.32 million and capital expenditures -$29,000, giving a free cash flow of -$12.35 million.

Operating Cash Flow -12.32M
Capital Expenditures -29,000
Free Cash Flow -12.35M
FCF Per Share -$0.11
Full Cash Flow Statement

Margins

Gross Margin -183.84%
Operating Margin -304.78%
Pretax Margin -732.46%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.19%
Shareholder Yield -27.19%
Earnings Yield -85.28%
FCF Yield -8.09%

Analyst Forecast

The average price target for ACRS is $9.71, which is 588.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.71
Price Target Difference 588.65%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 35.94%
EPS Growth Forecast (5Y) -10.18%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ACRS has an Altman Z-Score of -5.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.02
Piotroski F-Score 2